Reports for EMTRICITABINE
Ingredient
EMTRICITABINE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Resolved | 2019-07-29 | 2019-09-26 | 90113 |
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 300MG 200MG | TABLET | Avoided shortage | 2020-05-06 | 2020-05-12 | 114152 |
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 200MG 300MG | TABLET | Resolved | 2022-01-26 | 2022-02-04 | 153490 |
AURO-EMTRICITABINE-TENOFOVIR | 200MG 300MG | TABLET | Actual shortage | 2024-03-27 | 2024-05-24 | 223603 |
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 300MG 200MG | TABLET | Resolved | 2022-08-15 | 2022-10-24 | 166805 |
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 200MG 300MG | TABLET | Avoided shortage | 2020-12-07 | 2021-02-03 | 129766 |
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2021-04-12 | 2021-06-03 | 137370 |
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2023-09-15 | 2023-11-13 | 204524 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
Showing 1 to 1 of 1